|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61P 3/10 | (2006.01) |
| (11) | Number of the document | 3826662 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19749938.7 |
| Date of filing the European patent application | 2019-07-22 | |
| (97) | Date of publication of the European application | 2021-06-02 |
| (45) | Date of publication and mention of the grant of the patent | 2024-09-11 |
| (46) | Date of publication of the claims translation | 2024-11-25 |
| (86) | Number | PCT/US2019/042824 |
| Date | 2019-07-22 |
| (87) | Number | WO 2020/023388 |
| Date | 2020-01-30 |
| (30) | Number | Date | Country code |
| 201862702180 P | 2018-07-23 | US | |
| 201862730562 P | 2018-09-13 | US | |
| 201862740640 P | 2018-10-03 | US |
| (72) |
ALSINA-FERNANDEZ, Jorge , US
CABRERA, Over , US
COSKUN, Tamer , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | GIP / GLP1 koagonisto naudojimo būdas diabetui gydyti |
| METHOD OF USING A GIP/GLP1 CO-AGONIST FOR DIABETES |
| Payment date | Validity (years) | Amount | |
| 2026-06-18 | 8 | 185.00 EUR |
| 2027-07-22 |